Clinical Trials Directory

Trials / Sponsors / Inotek Pharmaceuticals Corporation

Inotek Pharmaceuticals Corporation

Industry · 7 registered clinical trials.

StatusTrialPhaseStarted
CompletedStudy of Fixed-Dose Combinations of Trabodenoson and Latanoprost in Adults With OHT or POAG
Primary Open-Angle Glaucoma (POAG), Ocular Hypertension (OHT)
Phase 22016-08-19
CompletedStudy of Trabodenoson in Adults With Ocular Hypertension or Primary Open-angle Glaucoma
Primary Open-Angle Glaucoma (POAG), Ocular Hypertension (OHT)
Phase 32015-09-01
CompletedA Phase II Study to Evaluate the Additivity of Trabodenoson to Latanoprost in Adults With Ocular Hypertension
Primary Open-Angle Glaucoma (POAG), Ocular Hypertension (OHT)
Phase 22013-08-01
CompletedA Dose-Escalation Study Designed to Evaluate the Tolerability, Safety, Pharmacokinetics (PK), and Efficacy of
Glaucoma, Ocular Hypertension
Phase 1 / Phase 22010-05-01
CompletedPhase I Dose-Escalation Study to Evaluate Tolerability, Safety & PK of INO-8875 in Healthy Older-Adult Volunte
Health
Phase 12010-05-01
TerminatedA Trial of INO-1001 in Patients Undergoing Heart Surgery That Involves Heart-lung Bypass
Heart Diseases, Postoperative Complications
Phase 22005-10-01
CompletedA Study of INO-1001, an Intravenous PARP (Poly [ADP Ribose] Polymerase) Inhibitor in Acute Heart Attack Patien
Acute Myocardial Infarction
Phase 22004-01-01